Generation of gene-corrected isogenic control cell lines from a DYT1 dystonia patient iPSC line carrying a heterozygous GAG mutation in TOR1A gene.


Journal

Stem cell research
ISSN: 1876-7753
Titre abrégé: Stem Cell Res
Pays: England
ID NLM: 101316957

Informations de publication

Date de publication:
07 2022
Historique:
received: 11 04 2022
revised: 26 04 2022
accepted: 02 05 2022
pubmed: 10 5 2022
medline: 22 6 2022
entrez: 9 5 2022
Statut: ppublish

Résumé

Childhood-onset torsin dystonia (DYT1) is a rare hereditary movement disorder and usually caused by a heterozygous GAG deletion (c.907-909) in the TOR1A gene (ΔE, p.Glu303del). The neuronal functions of torsin proteins and the pathogenesis of ΔE mutation are not clear. Previously, we have generated a hiPSC line from DYT1 patient fibroblast cells. In this study, we genetically corrected GAG deletion and obtained two isogenic control lines. These hiPSC lines contain the wild-type TOR1A sequence, showed the normal stem cell morphology and karyotype, expressed pluripotency markers, and differentiated into three germ layers, providing a valuable resource in DYT1 research.

Identifiants

pubmed: 35533513
pii: S1873-5061(22)00156-8
doi: 10.1016/j.scr.2022.102807
pmc: PMC9366766
mid: NIHMS1817668
pii:
doi:

Substances chimiques

Molecular Chaperones 0
TOR1A protein, human 0

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

102807

Subventions

Organisme : NINDS NIH HHS
ID : R21 NS112910
Pays : United States

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.

Références

Stem Cell Res. 2021 May;53:102277
pubmed: 33706202
Stem Cell Res. 2021 Oct;56:102536
pubmed: 34536661
J Neurosci. 2021 Mar 3;41(9):2024-2038
pubmed: 33468570
Neuron. 2005 Dec 22;48(6):923-32
pubmed: 16364897
STAR Protoc. 2022 Mar 10;3(1):101223
pubmed: 35300000

Auteurs

Masuma Akter (M)

Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, LA 71130-3932, USA; Department of Biology, University of Louisiana at Lafayette, Lafayette LA 70503, USA.

Haochen Cui (H)

Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, LA 71130-3932, USA.

Yi-Hsien Chen (YH)

Genome Engineering and iPSC Center (GEiC), Washington University in St Louis, MO 63110, USA.

Baojin Ding (B)

Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, LA 71130-3932, USA. Electronic address: baojin.ding@lsuhs.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH